» Articles » PMID: 18508664

Chemokines: Coded Messages for T-cell Missions

Overview
Journal Front Biosci
Specialty Biology
Date 2008 May 30
PMID 18508664
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Chemokines and their receptors control leukocyte migration and homing throughout the body in both physiological and pathological conditions. In the context of the adaptive immune system, which requires high efficiency and control, chemokines and chemokine receptors represent a versatile code that orchestrates the "who, where and when" of the immune response by providing the spatio-temporal guidance for T-cell development, priming and effector functions. In addition to their chemotactic properties, chemokines can directly modulate T-cell responses by amplifying signals at the immune synapse and tuning Th1/Th2 polarization. In this review we will discuss the role of chemokines in T-cell biology, following an ideal pilgrimage that spans the key steps of the T-cell life.

Citing Articles

Influence of Culture Conditions on Ex Vivo Expansion of T Lymphocytes and Their Function for Therapy: Current Insights and Open Questions.

Sudarsanam H, Buhmann R, Henschler R Front Bioeng Biotechnol. 2022; 10:886637.

PMID: 35845425 PMC: 9277485. DOI: 10.3389/fbioe.2022.886637.


Endothelial Activation in Infection Is Mediated by Cytokine Secretion From Infected Monocytes.

Tantibhedhyangkul W, Matamnan S, Longkunan A, Boonwong C, Khowawisetsut L Front Cell Infect Microbiol. 2021; 11:683017.

PMID: 34368012 PMC: 8340038. DOI: 10.3389/fcimb.2021.683017.


Immediate Effects of Dasatinib on the Migration and Redistribution of Naïve and Memory Lymphocytes Associated With Lymphocytosis in Chronic Myeloid Leukemia Patients.

Colom-Fernandez B, Kreutzman A, Marcos-Jimenez A, Garcia-Gutierrez V, Cuesta-Mateos C, Portero-Sainz I Front Pharmacol. 2019; 10:1340.

PMID: 31824308 PMC: 6886582. DOI: 10.3389/fphar.2019.01340.


Tumor-infiltrating lymphocytes from human prostate tumors reveal anti-tumor reactivity and potential for adoptive cell therapy.

Yunger S, Bar El A, Zeltzer L, Fridman E, Raviv G, Laufer M Oncoimmunology. 2019; 8(12):e1672494.

PMID: 31741775 PMC: 6844325. DOI: 10.1080/2162402X.2019.1672494.


LFA-1 activates focal adhesion kinases FAK1/PYK2 to generate LAT-GRB2-SKAP1 complexes that terminate T-cell conjugate formation.

Raab M, Lu Y, Kohler K, Smith X, Strebhardt K, Rudd C Nat Commun. 2017; 8:16001.

PMID: 28699640 PMC: 5510181. DOI: 10.1038/ncomms16001.